{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:07:27Z","timestamp":1787731647549,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI106705"],"award-info":[{"award-number":["5P01AI106705"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI106705"],"award-info":[{"award-number":["5P01AI106705"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5R01NS083687"],"award-info":[{"award-number":["5R01NS083687"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001515","name":"Britton Fund","doi-asserted-by":"publisher","award":["Charles S. Britton Fund"],"award-info":[{"award-number":["Charles S. Britton Fund"]}],"id":[{"id":"10.13039\/100001515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The presence of abnormal, disease-related prion protein (PrP<jats:sup>D<\/jats:sup>) has recently been demonstrated by protein misfolding cyclic amplification (PMCA) in urine of patients affected with variant Creutzfeldt-Jakob disease (vCJD), a prion disease typically acquired from consumption of prion contaminated bovine meat. The complexity and multistage process of urine excretion along with the obligatory use of PMCA raise the issue of whether strain characteristics of the PrP<jats:sup>D<\/jats:sup> present in vCJD brains, such as infectivity and phenotype determination, are maintained in urine excreted PrP<jats:sup>D<\/jats:sup> and following amplification by PMCA. We inoculated transgenic mice expressing normal human PrP with amplified urine and brain homogenate achieving the same 100% attack rate, similar incubation periods (in both cases extremely long) and histopathological features as for type and severity of the lesions. Furthermore, PrP<jats:sup>D<\/jats:sup> characteristics analyzed by immunoblot and conformational stability immunoassay were indistinguishable. Inoculation of raw vCJD urine caused no disease, confirming the extremely low concentration of PrP<jats:sup>D<\/jats:sup> in vCJD urine. These findings show that strain characteristics of vCJD brain PrP<jats:sup>D<\/jats:sup>, including infectivity, are preserved in PrP<jats:sup>D<\/jats:sup> present in urine and are faithfully amplified by means of PMCA; moreover, they suggest that the PrP<jats:sup>D<\/jats:sup> urine test might allow for the diagnosis and identification of disease subtype also in sporadic CJD.<\/jats:p>","DOI":"10.1038\/s41598-019-41694-0","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T11:03:26Z","timestamp":1553598206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study"],"prefix":"10.1038","volume":"9","author":[{"given":"Ignazio","family":"Cali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Lavrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Moda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Kofskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish Kumar","family":"Nemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tagliavini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Gambetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Notari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"41694_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-010-0761-3","volume":"121","author":"P Gambetti","year":"2011","unstructured":"Gambetti, P. et al. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol 121, 79\u201390 (2011).","journal-title":"Acta Neuropathol"},{"key":"41694_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/bs.pmbts.2017.06.011","volume":"150","author":"DL Ritchie","year":"2017","unstructured":"Ritchie, D. L. & Ironside, J. W. Neuropathology of Human Prion Diseases. Prog Mol Biol Transl Sci 150, 319\u2013339 (2017).","journal-title":"Prog Mol Biol Transl Sci"},{"key":"41694_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","volume":"164","author":"MW Head","year":"2004","unstructured":"Head, M. W. et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 164, 143\u2013153 (2004).","journal-title":"Am J Pathol"},{"key":"41694_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce, M. E. et al. Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent. Nature 389, 498\u2013501 (1997).","journal-title":"Nature"},{"key":"41694_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/38925","volume":"389","author":"AF Hill","year":"1997","unstructured":"Hill, A. F. et al. The same prion strain causes vCJD and BSE. Nature 389, 448\u2013450 (1997).","journal-title":"Nature"},{"key":"41694_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nri3553","volume":"13","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi, A., Nuvolone, M. & Zhu, C. The immunobiology of prion diseases. Nat Rev Immunol 13, 888\u2013902 (2013).","journal-title":"Nat Rev Immunol"},{"key":"41694_CR7","doi-asserted-by":"publisher","first-page":"9532","DOI":"10.1128\/JVI.01544-15","volume":"89","author":"DS Donaldson","year":"2015","unstructured":"Donaldson, D. S., Else, K. J. & Mabbott, N. A. The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis. J Virol 89, 9532\u20139547 (2015).","journal-title":"J Virol"},{"key":"41694_CR8","doi-asserted-by":"crossref","unstructured":"Mabbott, N. A. How do PrPSc Prions Spread between Host Species, and within Hosts? Pathogens 6(4) (2017).","DOI":"10.3390\/pathogens6040060"},{"issue":"1","key":"41694_CR9","doi-asserted-by":"publisher","first-page":"e8765","DOI":"10.1371\/journal.pone.0008765","volume":"5","author":"S Notari","year":"2010","unstructured":"Notari, S. et al. Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One 5(1), e8765 (2010).","journal-title":"PLoS One"},{"key":"41694_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3201\/eid2306.161734","volume":"23","author":"JY Douet","year":"2017","unstructured":"Douet, J. Y. et al. Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients. Emerg Infect Dis 23, 946\u2013956 (2017).","journal-title":"Emerg Infect Dis"},{"key":"41694_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1056\/NEJMoa1404401","volume":"371","author":"F Moda","year":"2014","unstructured":"Moda, F. et al. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med 371, 530\u2013539 (2014).","journal-title":"N Engl J Med"},{"key":"41694_CR12","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1001\/jamaneurol.2016.3733","volume":"73","author":"C Luk","year":"2016","unstructured":"Luk, C. et al. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine. JAMA Neurol 73, 1454\u20131460 (2016).","journal-title":"JAMA Neurol"},{"key":"41694_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-4939-7244-9_18","volume":"1658","author":"A Boyle","year":"2017","unstructured":"Boyle, A., Hogan, K., Manson, J. C. & Diack, A. B. Strain Typing of Prion Diseases Using In Vivo Mouse Models. Methods Mol Biol 1658, 263\u2013283 (2017).","journal-title":"Methods Mol Biol"},{"key":"41694_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3201\/eid1801.110589","volume":"18","author":"S Notari","year":"2012","unstructured":"Notari, S. et al. Assessing prion infectivity of human urine in sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis 18, 21\u201328 (2012).","journal-title":"Emerg Infect Dis"},{"key":"41694_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1126\/science.1118829","volume":"310","author":"H Seeger","year":"2005","unstructured":"Seeger, H. et al. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310, 324\u2013326 (2005).","journal-title":"Science"},{"key":"41694_CR16","doi-asserted-by":"publisher","first-page":"30489","DOI":"10.1074\/jbc.M110.161794","volume":"285","author":"A Dagdanova","year":"2010","unstructured":"Dagdanova, A. et al. Characterization of the prion protein in human urine. J Biol Chem 285, 30489\u201330495 (2010).","journal-title":"J Biol Chem"},{"key":"41694_CR17","doi-asserted-by":"publisher","first-page":"10940","DOI":"10.1073\/pnas.89.22.10940","volume":"89","author":"M Gasset","year":"1992","unstructured":"Gasset, M. et al. Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci USA 89, 10940\u201310944 (1992).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41694_CR18","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1073\/pnas.90.20.9678","volume":"90","author":"F Tagliavini","year":"1993","unstructured":"Tagliavini, F. et al. Synthetic peptides homologous to prion protein residues 106\u2013147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 90, 9678\u20139682 (1993).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41694_CR19","doi-asserted-by":"publisher","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","volume":"270","author":"SG Chen","year":"1995","unstructured":"Chen, S. G. et al. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270, 19173\u201319180 (1995).","journal-title":"J Biol Chem"},{"key":"41694_CR20","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.1073\/pnas.93.26.15457","volume":"93","author":"T Muramoto","year":"1996","unstructured":"Muramoto, T., Scott, M., Cohen, F. E. & Prusiner, S. B. Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci USA 93, 15457\u201315462 (1996).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41694_CR21","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1074\/jbc.M610051200","volume":"282","author":"L Solforosi","year":"2007","unstructured":"Solforosi, L. et al. Toward molecular dissection of PrPC-PrPSc interactions. J Biol Chem 282, 7465\u20137471 (2007).","journal-title":"J Biol Chem"},{"key":"41694_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","volume":"121","author":"J Castilla","year":"2005","unstructured":"Castilla, J., Sa\u00e1, P., Hetz, C. & Soto, C. In vitro generation of infectious scrapie prions. Cell 121, 195\u2013206 (2005).","journal-title":"Cell"},{"key":"41694_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3201\/eid1502.081173","volume":"15","author":"KD Meade-White","year":"2009","unstructured":"Meade-White, K. D. et al. Characteristics of 263K scrapie agent in multiple hamster species. Emerg Infect Dis 15, 207\u2013215 (2009).","journal-title":"Emerg Infect Dis"},{"key":"41694_CR24","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1016\/j.febslet.2008.08.003","volume":"582","author":"D Gonzalez-Romero","year":"2008","unstructured":"Gonzalez-Romero, D., Barria, M. A., Leon, P., Morales, R. & Soto, C. Detection of infectious prions in urine. FEBS Lett 582, 3161\u20133166 (2008).","journal-title":"FEBS Lett"},{"key":"41694_CR25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3201\/eid1109.050371","volume":"11","author":"ED Belay","year":"2005","unstructured":"Belay, E. D. et al. Variant Creutzfeldt-Jakob disease death, United States. Emerg Infect Dis 11, 1351\u20131354 (2005).","journal-title":"Emerg Infect Dis"},{"key":"41694_CR26","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1523\/JNEUROSCI.2467-05.2005","volume":"25","author":"Q Kong","year":"2005","unstructured":"Kong, Q. et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 25, 7944\u20137949 (2005).","journal-title":"J Neurosci"},{"key":"41694_CR27","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1128\/jvi.61.12.3688-3693.1987","volume":"61","author":"RJ Kascsak","year":"1987","unstructured":"Kascsak, R. J. et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61, 3688\u20133693 (1987).","journal-title":"J Virol"},{"key":"41694_CR28","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3201\/eid2012.140548","volume":"20","author":"S Notari","year":"2014","unstructured":"Notari, S. et al. Transmission characteristics of variably protease-sensitive prionopathy. Emerg Infect Dis 20, 2006\u20132014 (2014).","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"41694_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40478-017-0503-z","volume":"6","author":"I Cali","year":"2018","unstructured":"Cali, I. et al. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-\u03b2 pathology: an international study. Acta Neuropathol Commun 6(1), 5 (2018).","journal-title":"Acta Neuropathol Commun"},{"key":"41694_CR30","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1073\/pnas.0307825100","volume":"101","author":"WQ Zou","year":"2004","unstructured":"Zou, W. Q., Zheng, J., Gray, D. M., Gambetti, P. & Chen, S. G. Antibody to DNA detects scrapie but not normal prion protein. ProcNatl Acad Sci USA 101, 1380\u20131385 (2004).","journal-title":"ProcNatl Acad Sci USA"},{"key":"41694_CR31","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0002-9440(10)61254-0","volume":"167","author":"M Pastore","year":"2005","unstructured":"Pastore, M. et al. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Am J Pathol 167, 1729\u20131738 (2005).","journal-title":"Am J Pathol"},{"key":"41694_CR32","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/brain\/awp196","volume":"132","author":"I Cali","year":"2009","unstructured":"Cali, I. et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132, 2643\u20132658 (2009).","journal-title":"Brain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41694-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:07:59Z","timestamp":1671264479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41694"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41694-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Soto is inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a biotech company focusing on the commercial utilization of PMCA for prion diagnosis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5191"}}